| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 12/03/2009 | WO2009144738A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 12/03/2009 | CA2721665A1 Compounds including an anti-inflammatory pharmacore and methods of use |
| 12/02/2009 | EP2125858A2 Pharmaceutically acceptable salts of 11-(4-aminophenyl)-19-norpregna-4,9(10)-diene-3,20-dione derivatives |
| 12/01/2009 | CA2362503C Double metal cyanide catalysts for producing polyether polyols |
| 11/25/2009 | EP2121724A2 Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 11/24/2009 | CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 11/19/2009 | US20090286973 Ligand-conjugated monomers |
| 11/18/2009 | EP2118120A1 Nitric oxide releasing steroids |
| 11/17/2009 | CA2406847C Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols |
| 11/11/2009 | EP2114982A1 Modulators of hypoxia inducible factor-1 and related uses |
| 11/11/2009 | EP2114415A1 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 11/11/2009 | CN100558741C 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 11/04/2009 | EP2112995A2 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 10/28/2009 | EP2111409A1 Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent |
| 10/28/2009 | CN101568547A Substituted estratrien derivatives as 17beta hsd inhibitors |
| 10/22/2009 | WO2009082819A8 Novel lupane derivatives |
| 10/21/2009 | EP2109618A1 Nitric oxide releasing steroids |
| 10/21/2009 | EP2109617A1 Nitric oxide releasing steroids |
| 10/21/2009 | CN100551902C Photoactive materials |
| 10/20/2009 | US7605151 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 10/15/2009 | WO2009054725A3 Means and methods for counteracting muscle disorders |
| 10/14/2009 | CN101558079A Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 10/13/2009 | CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 10/08/2009 | WO2009122435A2 A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine |
| 10/07/2009 | EP1358201B1 A process for the preparation of 3-glutamido bile ester derivatives using n-protected methyl pyroglutamate |
| 10/06/2009 | US7598234 Steroid derived antibiotics |
| 09/30/2009 | EP1963355B1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/24/2009 | WO2009083268A3 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 09/16/2009 | EP2099814A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 09/09/2009 | EP2097437A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 09/09/2009 | CN101528764A Compositions and methods for suppressing endometrial proliferation |
| 09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/03/2009 | WO2009082818A8 Novel c-21-keto lupane derivatives preparation and use thereof |
| 09/03/2009 | US20090221841 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 09/03/2009 | US20090221543 New corticosteroids |
| 08/27/2009 | US20090215044 Receptor in Dendritic Cells |
| 08/25/2009 | CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa |
| 08/20/2009 | US20090209506 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes |
| 08/19/2009 | EP2088865A2 Guggulphospholipid methods and compositions |
| 08/18/2009 | US7576226 oximation of d-norgestrel to form d-(17 alpha )-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3E- and -3Z-oxime isomers, used as contraceptives; hormone replacement therapy |
| 08/13/2009 | US20090203662 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
| 08/12/2009 | EP1294402B2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 08/12/2009 | CN101503454A Compound for preparing cholic acid conjugate, preparation and use thereof |
| 08/12/2009 | CN100526328C 17beta-hydroxysteroid dehydrogenase inhibitors. |
| 08/05/2009 | EP2083621A2 Modulators of amyloid-beta production |
| 07/22/2009 | CN101490077A Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators |
| 07/16/2009 | WO2009053439A3 An amorphous form of an anti-inflammatory compound |
| 07/15/2009 | EP2078032A2 Compositions and methods for suppressing endometrial proliferation |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/09/2009 | WO2009083268A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009082819A1 Novel lupane derivatives |
| 07/09/2009 | WO2009082818A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | US20090176754 Crystalline Form of the Compound A-348441 |
| 07/09/2009 | CA2711424A1 Novel lupane derivatives |
| 07/09/2009 | CA2711420A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | CA2710934A1 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and medicinal products containing the derivative |
| 07/07/2009 | US7557097 solid form; aminosteroid disulfate derivatives; petromyzonamine disulfate |
| 06/30/2009 | US7553830 Compositions for the delivery of negatively charged molecules |
| 06/25/2009 | WO2009027994A4 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 06/24/2009 | CN101466725A Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 06/24/2009 | CN101466724A Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyde-(E)-oxime (Asoprisnil) |
| 06/24/2009 | CN101463063A Method for synthesizing 3 alpha-hydroxy-2 beta-amidine-5 alpha-androst-17-keto compound |
| 06/23/2009 | US7550452 N-Cholesteryloxyethylammonium (or amine) salt derivatives; compatible to gene therapy due to stability and highly transporting effects; drug delivery |
| 06/23/2009 | US7550451 Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/17/2009 | EP2070942A1 Method for aromatising 19-nor-androst-4-en-3-ones to estra-1,3,5(10)-trienes |
| 06/17/2009 | EP2070941A1 Stereoselective synthesis of selective estrogen receptor down-regulators |
| 06/17/2009 | EP2069500A2 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 06/11/2009 | WO2001070093A3 Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/10/2009 | CN100497368C Pure d-(17 alpha)-13-ethyl -17-hydroxy-18, 19-dinorpregn-4- ene-20- yne-3-one -3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers |
| 06/09/2009 | CA2273354C Oxyiminopregnanecarbolactones |
| 05/28/2009 | WO2008071960A3 Methods of increasing neurogenesis |
| 05/27/2009 | EP1395544A4 Methods of making 21- 4'-(nitrooxyalkyl) benzoate corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 05/27/2009 | CN100491392C Blanched polyamine steroid derivatives |
| 05/26/2009 | US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 05/26/2009 | US7538093 Compositions and methods for therapeutic use |
| 05/21/2009 | US20090131384 Compounds and methods for treatment of disorders associated with er stress |
| 05/20/2009 | EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/19/2009 | US7534769 Cholic acid or deoxycholic acid derivatives can include polypeptides, polynucleotides such as genes and antisense nucleic acids that can modulate cellular activity |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 05/06/2009 | EP1430074B1 Aminoglycoside lipid derivatives for transfection |
| 05/06/2009 | EP1363933B1 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
| 04/30/2009 | WO2009054725A2 Means and methods for counteracting muscle disorders |
| 04/30/2009 | WO2009053439A2 An amorphous form of an anti-inflammatory compound |
| 04/30/2009 | WO2008152112A3 17ß-CYANO-19-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 04/30/2009 | CA2704049A1 Means and methods for counteracting muscle disorders |
| 04/30/2009 | CA2703441A1 An amorphous form of an anti-inflammatory compound |
| 04/29/2009 | CN100482676C N-oxy-group-contained lipids |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524821 Scaffolded maleimide clusters for multivalent peptide assembly |
| 04/23/2009 | WO2009050483A1 Cationic lipids |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | CA2702862A1 Cationic lipids |
| 04/16/2009 | WO2009047101A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 04/16/2009 | WO2009047006A2 Amphoteric liposomes comprising neutral lipids |
| 04/16/2009 | WO2009027994A3 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 04/16/2009 | WO2008134668A3 Heat-labile prodrugs |
| 04/16/2009 | CA2702111A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |